Free Trial
NYSE:TMO

Thermo Fisher Scientific Q3 2025 Earnings Report

Thermo Fisher Scientific logo
$526.48 +0.66 (+0.12%)
As of 11:13 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Thermo Fisher Scientific EPS Results

Actual EPS
N/A
Consensus EPS
$5.51
Beat/Miss
N/A
One Year Ago EPS
N/A

Thermo Fisher Scientific Revenue Results

Actual Revenue
N/A
Expected Revenue
$10.90 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Thermo Fisher Scientific Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Wednesday, October 22, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Thermo Fisher Scientific Earnings Headlines

The 7 Warning Signals Flashing Red Right Now
A free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. Right now, all seven are flashing red simultaneously for the first time since 2007. These aren't the signals you'll see on CNBC.tc pixel
See More Thermo Fisher Scientific Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Thermo Fisher Scientific? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Thermo Fisher Scientific and other key companies, straight to your email.

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE:TMO) is a leading provider of scientific instruments, reagents and consumables, software, and services that advance research, diagnostics, and pharmaceutical manufacturing. The company’s main business activities are organized into four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Its product offerings include benchtop and high-throughput instruments, chromatography and mass spectrometry systems, cell culture media, antibodies and assays, clinical diagnostic kits, and custom biopharma development and manufacturing services.

Formed in 2006 through the merger of Thermo Electron and Fisher Scientific, Thermo Fisher has built a global reputation by combining deep domain expertise with broad product portfolios. Over the years, it has expanded both organically and through targeted acquisitions to address emerging challenges in genomics, proteomics, clinical diagnostics, personalized medicine, and environmental testing. The company continues to invest in research and development, aiming to deliver novel solutions that accelerate scientific discovery and improve patient outcomes.

Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific operates in more than 50 countries and serves customers across North America, Europe, Asia Pacific, Latin America, and the Middle East. Its geographic reach supports a diverse clientele, including academic institutions, government agencies, hospitals, pharmaceutical and biotechnology companies, and industrial laboratories. The company’s logistics network and field service teams are designed to ensure reliable product delivery, technical support, and application training on a global scale.

Under the leadership of President and Chief Executive Officer Marc N. Casper, Thermo Fisher Scientific maintains a focus on innovation, operational excellence, and sustainable growth. The company emphasizes collaboration with its customers and partners to co-develop solutions that address complex scientific and healthcare challenges. By aligning strategic investments with evolving market needs, Thermo Fisher seeks to reinforce its position as a trusted partner in the global life sciences and diagnostics ecosystem.

View Thermo Fisher Scientific Profile

More Earnings Resources from MarketBeat